These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8928988)

  • 41. Second primary cancer after major salivary gland carcinoma.
    Hirvonen K; Rantanen M; Haapaniemi A; Pitkäniemi J; Malila N; Mäkitie AA
    Head Neck; 2018 Feb; 40(2):251-258. PubMed ID: 28960648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
    Schenk M; Severson RK; Pawlish KS
    Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.
    Murray KS; Zabor EC; Spaliviero M; Russo P; Bazzi WM; Musser JE; Ari Hakimi A; Bernstein ML; Dalbagni G; Coleman JA; Furberg H
    World J Urol; 2016 Dec; 34(12):1667-1672. PubMed ID: 27106493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer risk among Danish women with cosmetic breast implants.
    Friis S; Hölmich LR; McLaughlin JK; Kjøller K; Fryzek JP; Henriksen TF; Olsen JH
    Int J Cancer; 2006 Feb; 118(4):998-1003. PubMed ID: 16152592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
    Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC
    Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second primary tumors after prostate carcinoma.
    Levi F; Randimbison L; Te VC; Erler G; La Vecchia C
    Cancer; 1999 Oct; 86(8):1567-70. PubMed ID: 10526286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are patients with skin cancer at lower risk of developing colorectal or breast cancer?
    Soerjomataram I; Louwman WJ; Lemmens VE; Coebergh JW; de Vries E
    Am J Epidemiol; 2008 Jun; 167(12):1421-9. PubMed ID: 18424428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations between ocular melanoma and other primary cancers: an international population-based study.
    Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
    Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basal-cell carcinoma of the skin: a harbinger of cutaneous and noncutaneous multiple primary cancer.
    Schottenfeld D
    Ann Intern Med; 1996 Nov; 125(10):852-4. PubMed ID: 8928994
    [No Abstract]   [Full Text] [Related]  

  • 53. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK; Khanal A
    Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980-2014: A nationwide study.
    Schmidt Jensen J; Grønhøj C; Ruud Kjær EK; Charabi BW; von Buchwald C; Hjuler T
    Int J Pediatr Otorhinolaryngol; 2019 Dec; 127():109648. PubMed ID: 31472358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
    Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
    BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients.
    Jaeger AB; Gramkow A; Hjalgrim H; Melbye M; Frisch M
    Arch Dermatol; 1999 Jul; 135(7):790-3. PubMed ID: 10411153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Merkel cell carcinoma and multiple primary cancers.
    Howard RA; Dores GM; Curtis RE; Anderson WF; Travis LB
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1545-9. PubMed ID: 16896047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
    Hemminki K; Dong C
    Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
    Farr DE; Thomas A; Khan SA; Schroeder MC
    Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.
    Murphy JD; Ma GL; Baumgartner JM; Madlensky L; Burgoyne AM; Tang CM; Martinez ME; Sicklick JK
    Cancer; 2015 Sep; 121(17):2960-7. PubMed ID: 25930983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.